Please login to the form below

Not currently logged in


This page shows the latest Apellis news and features for those working in and with pharma, biotech and healthcare.

FDA approves Apellis’ Empaveli for rare blood disease

FDA approves Apellis’ Empaveli for rare blood disease

Whereas Alexion’s Soliris and its follow-up therapy Ultomiris target the C5 pathway, Apellis’ drug targets the compliment protein C3 – the central protein in the complement cascade. ... Apellis is also conducting a study of Empaveli in

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Dr Robert Kim joins Apellis as chief medical officer Dr Robert Kim joins Apellis as chief medical officer

    Brings experience from Novartis, Genentech and GSK. Dr Robert Kim has taken up a role at Apellis Pharmaceuticals as chief medical officer, bringing to the US clinical stage immunotherapy company experience ... In his new role at Louisville,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Genesis Research

Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...